covid

A new study suggests that COVID patients are more likely to suffer from gastrointestinal issues a year after diagnosis than those that never had COVID. These issues include different forms of acid reflux, and peptic ulcers. A lower percentage of patients experience more seriously inflammatory…

Recent findings suggest that taking Paxlovid among those who are eligible for the drug both decreases the risk of hospitalization, as well as lowers the chances of long covid. The results of the study open the door to more questions about Paxlovid's efficacy, including if it can have these same…

Although the presence of prevention methods for COVID-19 have reduced prevalence of some contagious illnesses, others such as H.I.V, TB and Malaria have been put on the backburner in terms of testing and treatment. In countries that already struggle to treat and diagnose COVID-19 cases, the above…

On February 27, 2021, Johnson & Johnson’s vaccine candidate was granted emergency use authorization by the FDA, the third to join the group of COVID vaccines being shipped throughout the country. Johnson & Johnson vaccines only require one dose, unlike the vaccines developed by Moderna and…